Marken Announces Global Brokerage Management Services For Clinical Trial Materials

RESEARCH TRIANGLE PARK, N.C., Oct. 16, 2018 /PRNewswire/ -- Marken announced today the launch of their brokerage management services in conjunction with UPS Brokerage to create one seamless offering with optimal visibility and ease of use for clients.

The addition of this service will be a unique opportunity for clients to utilize an established brokerage system, coupled with Marken's experience as the leading clinical trial supply chain solution provider.  Marken's oversight and compliance expertise ensures that time-sensitive and critical clinical shipments will avoid Customs and participating government agency-related delays. Compliant and timely customs clearance are critical factors in maintaining product integrity during transit to investigator sites or directly to patients. In addition to the UPS Brokerage team, Marken also maintains relationships with brokers in each country who have local regulatory expertise which assures compliance with all current import/export regulations. 

With a global approach to brokerage management for clinical trials, Marken is able to ensure Customs entries are filed accurately, compliantly and timely. This service ensures all Importer of Record obligations are met, and exposure to fines, penalties and forfeiture are greatly reduced.  The service also allows clients to benefit from new trade programs, duty drawbacks and tax exemptions in a coordinated manner.

Dan Bell, Vice President, North America Operations & Global Regulatory Affairs, commented on the new service, "This is the first and only global brokerage service which is specifically tailored to clinical trials. The expansion of global brokerage services in the suite of client offerings ensures that our experienced team are able to maintain complete control and visibility of clinical trial shipments across international borders.  Using proprietary UPS software, we are able to provide detailed reports to our clients which assure both compliance and economies of scale."

About Marken
Marken is a wholly owned subsidiary of UPS. Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient and Home Health care services, biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 48 locations worldwide for clinical trial material storage and distribution. Marken's more than 900 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry.

SOURCE Marken